A Safety Study of XL019 in Adults With Myelofibrosis

Clinical trial NCT00522574 · TERMINATED

Trial details

NCT number: NCT00522574
Sponsor: Exelixis
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Myeloproliferative Disorders Myelofibrosis Polycythemia Vera Thrombocythemia, Essential

Start date: 2007-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.